Joshua S O'Connell1,2, Carol Lee1,2, Nassim Farhat1,2, Lina Antounians1,2, Augusto Zani1,3, Bo Li1,2, Agostino Pierro4,5. 1. Division of General and Thoracic Surgery, The Hospital for Sick Children, Toronto, ON, Canada. 2. Translational Medicine Program, The Hospital for Sick Children, Toronto, ON, Canada. 3. Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, ON, Canada. 4. Division of General and Thoracic Surgery, The Hospital for Sick Children, Toronto, ON, Canada. agostino.pierro@sickkids.ca. 5. Translational Medicine Program, The Hospital for Sick Children, Toronto, ON, Canada. agostino.pierro@sickkids.ca.
Abstract
PURPOSE: Necrotizing enterocolitis (NEC) is a devastating gastrointestinal disease. Amniotic fluid stem cells (AFSC) improve NEC injury but human translation remains difficult. We aimed to evaluate the use of extracellular vesicles (EV) derived from human AFSC. METHODS: Human AFSC (hAFSC) were cultured according to the protocol (Celprogen Inc., California, U.S.A.). Conditioned medium was obtained, ultra-centrifuged, and EV were suspended in phosphate-buffered saline (PBS). C57BL/6 pups were grouped into: (1) breast-fed (Control, n = 11); (2) NEC + placebo (NEC + PBS; n = 10); and (3) NEC + treatment (NEC + EV; n = 11). NEC was induced post-natal days P5-9 by (A) gavage feeding hyperosmolar formula; (B) hypoxia for 10 min; and (C) lipopolysaccharide. Intra-peritoneal injections of PBS or hAFSC-EV were given on P6-7. All animals were sacrificed on P9 and terminal ileum harvested. RESULTS: hAFSC-EV administration reduced intestinal injury (p = 0.0048), NEC incidence (score ≥ 2), and intestinal inflammation (IL-6 p < 0.0001; TNF-α p < 0.0001). Intestinal stem cell expression (Lgr5 +) and cellular proliferation (Ki67) were enhanced above control levels following hAFSC-EV administration (Lgr5 p = 0.0003; Ki67 p < 0.0001). CONCLUSION: hAFSC-EV administration reduced intestinal NEC injury and inflammation while increasing stem cell expression and cellular proliferation. hAFSC-EV administration may induce similar beneficial effects to exogenous stem cells.
PURPOSE:Necrotizing enterocolitis (NEC) is a devastating gastrointestinal disease. Amniotic fluid stem cells (AFSC) improve NEC injury but human translation remains difficult. We aimed to evaluate the use of extracellular vesicles (EV) derived from human AFSC. METHODS:Human AFSC (hAFSC) were cultured according to the protocol (Celprogen Inc., California, U.S.A.). Conditioned medium was obtained, ultra-centrifuged, and EV were suspended in phosphate-buffered saline (PBS). C57BL/6 pups were grouped into: (1) breast-fed (Control, n = 11); (2) NEC + placebo (NEC + PBS; n = 10); and (3) NEC + treatment (NEC + EV; n = 11). NEC was induced post-natal days P5-9 by (A) gavage feeding hyperosmolar formula; (B) hypoxia for 10 min; and (C) lipopolysaccharide. Intra-peritoneal injections of PBS or hAFSC-EV were given on P6-7. All animals were sacrificed on P9 and terminal ileum harvested. RESULTS:hAFSC-EV administration reduced intestinal injury (p = 0.0048), NEC incidence (score ≥ 2), and intestinal inflammation (IL-6 p < 0.0001; TNF-α p < 0.0001). Intestinal stem cell expression (Lgr5 +) and cellular proliferation (Ki67) were enhanced above control levels following hAFSC-EV administration (Lgr5 p = 0.0003; Ki67 p < 0.0001). CONCLUSION:hAFSC-EV administration reduced intestinal NEC injury and inflammation while increasing stem cell expression and cellular proliferation. hAFSC-EV administration may induce similar beneficial effects to exogenous stem cells.
Authors: Chhinder P Sodhi; Raheel Ahmad; Hongpeng Jia; William B Fulton; Carla Lopez; Andres J Gonzalez Salazar; Asuka Ishiyama; Maame Sampah; Steve Steinway; Sanxia Wang; Thomas Prindle; Menghan Wang; David L Steed; Howard Wessel; Ziv Kirshner; Larry R Brown; Peng Lu; David J Hackam Journal: Am J Physiol Gastrointest Liver Physiol Date: 2022-07-12 Impact factor: 4.871
Authors: Joshua S O'Connell; Bo Li; Andrea Zito; Abdalla Ahmed; Marissa Cadete; Niloofar Ganji; Ethan Lau; Mashriq Alganabi; Nassim Farhat; Carol Lee; Simon Eaton; Robert Mitchell; Steve Ray; Paolo De Coppi; Ketan Patel; Agostino Pierro Journal: PLoS One Date: 2021-12-02 Impact factor: 3.240
Authors: Rimke Romee de Kroon; Tessa de Baat; Stefania Senger; Mirjam Maria van Weissenbruch Journal: Front Pediatr Date: 2022-03-14 Impact factor: 3.418